Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The C-terminal domain of RD3 enables accumulation of retinal membrane guanylyl cyclase (RetGC) in photoreceptor outer segment.

The Journal of biological chemistry·2026
Same author

Protein Inhibitor of Retinal Membrane Guanylyl Cyclase Rescues Mouse Rod Photoreceptors from <i>GUCY2D</i> Retinal Dystrophy.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Long Noncoding RNAs as Blood-Based Biomarkers of Diabetic Retinopathy.

Translational vision science & technology·2026
Same author

Protein inhibitor of retinal membrane guanylyl cyclase suppresses cGMP synthesis in photoreceptors.

The Journal of biological chemistry·2025
Same author

Clinical and Biochemical Characterization of Specific GUCY2D Alleles Associated With a Rare Form of Night Blindness.

Investigative ophthalmology & visual science·2025
Same author

Phosphodiesterase 5 expression in photoreceptors rescues retinal degeneration induced by deregulation of membrane guanylyl cyclase.

The Journal of biological chemistry·2025

Related Experiment Video

Updated: Mar 2, 2026

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

8.2K

Optogenetic Approaches to Restoring Vision.

Zhuo-Hua Pan1,2, Qi Lu2, Anding Bi1

  • 1Department of Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan 48201; email: zhpan@med.wayne.edu , abi@med.wayne.edu , gabrams@med.wayne.edu.

Annual Review of Vision Science
|May 24, 2017
PubMed
Summary

Optogenetics can restore vision by making surviving retinal neurons light-sensitive, offering hope for blindness caused by photoreceptor loss. This approach shows promise for clinical applications in treating degenerative retinal diseases.

Keywords:
AAV vectorchannelrhodopsingene therapymicrobial rhodopsinretinal degeneration

More Related Videos

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits
07:43

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits

Published on: December 27, 2013

9.7K
Using Looming Visual Stimuli to Evaluate Mouse Vision
05:07

Using Looming Visual Stimuli to Evaluate Mouse Vision

Published on: June 13, 2019

12.4K

Related Experiment Videos

Last Updated: Mar 2, 2026

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

8.2K
Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits
07:43

Laser-scanning Photostimulation of Optogenetically Targeted Forebrain Circuits

Published on: December 27, 2013

9.7K
Using Looming Visual Stimuli to Evaluate Mouse Vision
05:07

Using Looming Visual Stimuli to Evaluate Mouse Vision

Published on: June 13, 2019

12.4K

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Biotechnology

Background:

  • Inherited and acquired retinal degenerative diseases cause photoreceptor cell loss, leading to vision impairment or blindness.
  • Current treatments for such conditions are limited, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To review the current status of optogenetic strategies for vision restoration.
  • To outline future directions and challenges for clinical application of optogenetics in treating blindness.

Main Methods:

  • Utilizing optogenetic tools, specifically microbial rhodopsins, to convert surviving inner retinal neurons into photosensitive cells.
  • Employing virus-mediated gene delivery for targeting specific retinal neurons and subcellular compartments.
  • Evaluating proof-of-concept studies demonstrating restored light responses and visually guided behaviors in animal models.

Main Results:

  • Optogenetic tools have successfully imparted light sensitivity to retinas lacking photoreceptor cells.
  • Significant advancements have been made in microbial rhodopsin-based tools and gene delivery systems.
  • Restoration of light responses and visually guided behaviors has been demonstrated in preclinical models.

Conclusions:

  • Optogenetics presents a viable strategy for vision restoration in cases of severe photoreceptor cell loss.
  • Further research and development are crucial for translating optogenetic therapies into clinical practice.
  • Addressing challenges in gene delivery, targeting, and tool optimization will improve outcomes for restored vision.